Barbara Natterson Horowitz, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biomimetics | 2 | 2020 | 173 | 0.630 |
Why?
|
| Environmental Health | 3 | 2020 | 283 | 0.580 |
Why?
|
| Water Pollutants, Chemical | 1 | 2021 | 354 | 0.570 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 1945 | 0.500 |
Why?
|
| Animals, Laboratory | 2 | 2021 | 46 | 0.500 |
Why?
|
| Cardiovascular System | 1 | 2020 | 835 | 0.430 |
Why?
|
| Ecology | 1 | 2023 | 103 | 0.420 |
Why?
|
| Animal Experimentation | 1 | 2021 | 46 | 0.390 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 1309 | 0.390 |
Why?
|
| Environmental Pollutants | 1 | 2021 | 1268 | 0.390 |
Why?
|
| Galectin 3 | 1 | 2023 | 240 | 0.370 |
Why?
|
| Allostasis | 1 | 2021 | 72 | 0.360 |
Why?
|
| Academies and Institutes | 1 | 2021 | 318 | 0.330 |
Why?
|
| Cardiology | 1 | 2020 | 1667 | 0.330 |
Why?
|
| Health | 1 | 2021 | 398 | 0.310 |
Why?
|
| Animal Diseases | 1 | 2017 | 12 | 0.290 |
Why?
|
| Myocarditis | 1 | 2023 | 765 | 0.260 |
Why?
|
| Affect | 1 | 2023 | 1480 | 0.250 |
Why?
|
| Problem-Based Learning | 1 | 2017 | 352 | 0.220 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2016 | 376 | 0.200 |
Why?
|
| Pericardium | 1 | 2006 | 674 | 0.200 |
Why?
|
| Reproduction | 1 | 2016 | 646 | 0.190 |
Why?
|
| Fishes | 2 | 2023 | 601 | 0.190 |
Why?
|
| Animals, Wild | 1 | 2021 | 77 | 0.190 |
Why?
|
| Human Characteristics | 1 | 2020 | 7 | 0.190 |
Why?
|
| Echocardiography | 2 | 2020 | 4962 | 0.190 |
Why?
|
| Tachycardia, Ventricular | 2 | 2006 | 1297 | 0.180 |
Why?
|
| Lens, Crystalline | 1 | 2023 | 388 | 0.180 |
Why?
|
| Heart Failure | 4 | 2023 | 11593 | 0.180 |
Why?
|
| Biological Evolution | 2 | 2020 | 1074 | 0.180 |
Why?
|
| Environmental Pollution | 1 | 2021 | 123 | 0.170 |
Why?
|
| Kidney Diseases | 1 | 2020 | 2082 | 0.170 |
Why?
|
| Zoonoses | 2 | 2022 | 178 | 0.160 |
Why?
|
| Life Style | 1 | 2019 | 3886 | 0.150 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 1884 | 0.150 |
Why?
|
| Communicable Disease Control | 1 | 2013 | 842 | 0.140 |
Why?
|
| Cataract | 1 | 2023 | 827 | 0.140 |
Why?
|
| Catheter Ablation | 2 | 2006 | 2741 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2021 | 3416 | 0.130 |
Why?
|
| Psychotropic Drugs | 1 | 2021 | 883 | 0.130 |
Why?
|
| Animals | 12 | 2023 | 167777 | 0.120 |
Why?
|
| Encephalitis | 1 | 2018 | 438 | 0.120 |
Why?
|
| Movement Disorders | 1 | 2018 | 459 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2017 | 3182 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2019 | 9265 | 0.120 |
Why?
|
| Public Health | 2 | 2017 | 2658 | 0.120 |
Why?
|
| Social Behavior | 1 | 2020 | 1132 | 0.110 |
Why?
|
| Mammals | 2 | 2023 | 1132 | 0.110 |
Why?
|
| Health Personnel | 1 | 2017 | 3311 | 0.110 |
Why?
|
| Aging | 1 | 2021 | 8650 | 0.100 |
Why?
|
| Knowledge | 1 | 2023 | 176 | 0.100 |
Why?
|
| Phylogeny | 2 | 2023 | 2774 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2016 | 6549 | 0.090 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2021 | 374 | 0.080 |
Why?
|
| Humans | 22 | 2023 | 757650 | 0.080 |
Why?
|
| Anxiety Disorders | 1 | 2018 | 2714 | 0.070 |
Why?
|
| Genetic Drift | 1 | 2016 | 41 | 0.070 |
Why?
|
| Social Environment | 1 | 2021 | 1021 | 0.070 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 150 | 0.060 |
Why?
|
| Models, Animal | 1 | 2021 | 2112 | 0.060 |
Why?
|
| Electric Countershock | 1 | 2006 | 533 | 0.060 |
Why?
|
| Pain | 1 | 2018 | 5063 | 0.050 |
Why?
|
| Environment | 1 | 2019 | 1118 | 0.050 |
Why?
|
| Monitoring, Intraoperative | 2 | 2008 | 939 | 0.050 |
Why?
|
| Epilepsy | 1 | 2018 | 3270 | 0.050 |
Why?
|
| Birds | 1 | 2023 | 168 | 0.050 |
Why?
|
| Fluoroscopy | 1 | 2006 | 944 | 0.050 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2008 | 1088 | 0.050 |
Why?
|
| Selection, Genetic | 1 | 2016 | 868 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2008 | 1094 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2022 | 2599 | 0.050 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 931 | 0.050 |
Why?
|
| Climate Change | 1 | 2017 | 486 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8601 | 0.040 |
Why?
|
| Eating | 1 | 2017 | 1537 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2016 | 2608 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1501 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 1294 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18123 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3560 | 0.040 |
Why?
|
| Heart Ventricles | 3 | 2006 | 3806 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2021 | 42044 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2003 | 609 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2006 | 1704 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3754 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2003 | 771 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2021 | 4374 | 0.040 |
Why?
|
| Defibrillators, Implantable | 1 | 2006 | 1487 | 0.040 |
Why?
|
| Prognosis | 3 | 2023 | 29493 | 0.030 |
Why?
|
| Demography | 1 | 2020 | 1645 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2006 | 5195 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 23681 | 0.030 |
Why?
|
| Education, Medical | 1 | 2017 | 1725 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2006 | 3072 | 0.030 |
Why?
|
| Incidence | 1 | 2023 | 21217 | 0.030 |
Why?
|
| Child | 1 | 2021 | 79787 | 0.030 |
Why?
|
| Adolescent | 1 | 2021 | 87832 | 0.030 |
Why?
|
| Risk Factors | 2 | 2023 | 73716 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 29720 | 0.020 |
Why?
|
| Female | 8 | 2023 | 389985 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 39018 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2003 | 3941 | 0.020 |
Why?
|
| Diet | 1 | 2017 | 8003 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 16533 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2006 | 5105 | 0.020 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2008 | 189 | 0.020 |
Why?
|
| Echocardiography, Four-Dimensional | 1 | 2006 | 14 | 0.020 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2006 | 352 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 81107 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17767 | 0.010 |
Why?
|
| United States | 1 | 2021 | 71907 | 0.010 |
Why?
|
| Patient Selection | 1 | 1995 | 4235 | 0.010 |
Why?
|
| Male | 6 | 2020 | 358227 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 2008 | 735 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2006 | 79982 | 0.010 |
Why?
|
| Middle Aged | 4 | 2008 | 219219 | 0.010 |
Why?
|
| ROC Curve | 1 | 2006 | 3562 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2003 | 12076 | 0.010 |
Why?
|
| Adult | 3 | 2008 | 219747 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 2278 | 0.010 |
Why?
|
| Aged | 2 | 2008 | 167889 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2003 | 10075 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2003 | 1808 | 0.010 |
Why?
|
| Cardiac Output, Low | 1 | 1995 | 191 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2006 | 4451 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2006 | 3858 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2003 | 2374 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2006 | 6363 | 0.010 |
Why?
|
| Sodium | 1 | 1995 | 1588 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 20039 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 10478 | 0.000 |
Why?
|
| Exercise Test | 1 | 1995 | 2121 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1995 | 4156 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20499 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1995 | 5951 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1995 | 12047 | 0.000 |
Why?
|
| Heart Transplantation | 1 | 1995 | 3220 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1995 | 5460 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2003 | 23819 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1995 | 15782 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2003 | 64242 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1995 | 54108 | 0.000 |
Why?
|